Companies dominating the Prefilled Saline Flush Syringes market are Becton, Dickinson and Company, B. Braun Medical Inc., and others.
Definition
Prefilled saline flush syringes are single-use syringes filled with sterile saline solution in various volumes, which are used to help prevent vascular access systems blockage and clear any medication that may be left at the catheter site. Prefilled saline flush syringes are filled with sterile saline, helping to reduce medication errors and contamination risks associated with multi-dose vials. Prefilled saline flush syringes also improve clinician efficiency and workflow by eliminating the steps and time involved in the manual preparation of saline syringes, and they are available in a variety of sizes. The companies involved in the prefilled saline flush syringes market are primarily engaged in the development, manufacturing, and marketing of prefilled saline flush syringe products.
Market by Type
Based on type, the global prefilled saline flush syringe market is segmented into 3 ml syringes, 5 ml syringes, 10 ml syringes, and others. Out of these, the 3 and 10 ml prefilled saline flush syringes are expected to lead the market in the coming years as they are the most convenient sizes and have higher adoption among the end-user segments. Moreover, the awareness of cross-contamination, medication errors, and benefits of prefilled saline flush syringes over conventional syringes lead to strong positioning of these segments in the overall market.
Market by Application
In terms of applications, the global prefilled saline flush syringes market is segmented into hospitals, clinics, and others such as homecare settings. Hospital and clinic segments pose a strong position in the market due to the high penetration of prefilled saline flush syringes due to rising healthcare concerns and changing government regulations to minimize errors in treatment. Moreover, Prefilled Saline Flush Syringes are widely used in the Intensive Care Unit. These end-user segments have a significant portion of revenue share in the overall market. The hospital segment is projected to lead the market as growing importance towards avoiding cross-contamination in hospitals. Besides, continuing growth of homecare settings to reduce the hospitals stay is expected to boost the growth of the prefilled saline flush syringes market. Further, rising awareness among the end users to increase patient compliance is expected to boost the growth of the prefilled saline flush syringes market.
Regional Analysis and Insights
North America dominates the Prefilled Saline Flush Syringes market, accounting for approximately 38.92% of revenue, followed by Europe and Asia Pacific, accounting for 27.88% and 27.60% respectively. Factors contributing to the growth of the North American market include an increase in the elderly population, rising cancer prevalence, favorable reimbursement for cancer treatment, and increased government and private healthcare spending.
Market Trends
‘Prefilled saline flush syringes reduce medication errors and contamination’
Increasing medication errors and risk of contamination in multi-dose vials are expected to boost the growth of the prefilled saline flush syringes market. Pre-filled syringes offer numerous advantages and are used commonly in flushing all vascular access devices. They prevent infection outbreaks and cross-contamination due to unit of use dose from large volume bags of normal saline and repetitive usage of multi-dose vials. Prefilled saline flush syringes are designed to prevent the solution from reentering into a non-sterile portion of the syringe and help to reduce contamination. These syringes are manufactured according to ISMP medication labeling and they help to reduce medication errors. Medication error is the failure in the treatment due to under prescribing, irrational and inappropriate prescribing, or overprescribing of the medication. Sometimes, medication errors also occur due to contamination, adulteration, wrong packaging, or erroneous adulteration. Furthermore, all the prefilled saline flush syringes are single-use devices and are not provided with any kind of preservatives. This attempt is used to save time and money for the end users and they are also incorporated with two sterilization processes, i.e., terminal sterilization and aseptic sterilization. These sterilization processes are to ensure product safety from contaminations.
‘Technological advancements’
Patient safety is now receiving well-determined attention to increasing the quality of life which increases the significant opportunities for manufacturing companies. Prefilled syringes are preferred over conventional vials, as they facilitate various benefits such as less over-filling, and safe and convenient use, which increases the demand for prefilled syringes. Pre-filled syringe saline delivery is convenient for patients, who need parenteral administration on a daily or weekly basis and long-term treatment. The demand for prefilled syringes is increasing as it is designed in accordance with patient acceptance and compliance. Technological advancements have made injections more user-friendly and convenient to perform. This has motivated patients & physicians to adopt prefilled syringes for chronic illness and other lifestyle-related diseases. Packaging technology for prefilled syringes is rapidly evolving with new polymers that are less prone to extractable and leachable and which provide better protection from drugs.
‘Increasing geriatric population’
Medical supplies are widely used for the geriatric population as it assists healthcare professionals to administer medication/ hormone/ nutrition and others. For instance, cancer is a major cause of morbidity and mortality in the aging population that is later primarily attributable to various chronic complications. The number of aging people with cancer is increasing due to increased lifespan and the increased prevalence of cancer in the geriatric population. Prefilled saline syringes are a regular requirement for cancer patients providing more flexibility while giving them greater control of the disease. The elderly population is defined as a group of people aged 65 and over. Population aging is poised to become one of the most significant social transformations of the twenty-first century. Today, there are more than 46 million older adults aged 65 and older living in the U.S.; by 2050, that number is expected to grow to almost 90 million. Between 2020 and 2030 alone, the time the last of the baby boom cohorts reach age 65, the number of older adults is projected to increase by almost 18 million. Elderly people are more likely to have cancer than younger people, and the effect of the disease on quality of life is particularly deep in this population. With an increase in the number of geriatric populations, the prevalence of chronic diseases has increased. Therefore, the demand for prefilled saline flush syringe products is expected to increase in the forecast period.
Top Companies
The prefilled saline flush syringes market is highly competitive and the major players include Becton, Dickinson and Company, B. Braun Medical Inc., Medefil, Medline Industries, Inc., Weigao Group, DBM, Cardinal Health, Amsino International Inc., MedXL, Nipro Corporation, Aquabiliti, McKesson Corporation, SteriCare Solutions, and Pentaferte Company.
|
Global Prefilled Saline Flush Syringes Revenue (M USD) by Top 3 Companies in 2023 | |
|
Becton, Dickinson and Company |
223.22 |
|
B. Braun Medical Inc. |
123.64 |
|
Medefil |
49.94 |
